GB0806230D0 - Antibodies - Google Patents

Antibodies

Info

Publication number
GB0806230D0
GB0806230D0 GB0806230A GB0806230A GB0806230D0 GB 0806230 D0 GB0806230 D0 GB 0806230D0 GB 0806230 A GB0806230 A GB 0806230A GB 0806230 A GB0806230 A GB 0806230A GB 0806230 D0 GB0806230 D0 GB 0806230D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0806230A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0806230A priority Critical patent/GB0806230D0/en
Publication of GB0806230D0 publication Critical patent/GB0806230D0/en
Priority to KR1020157022610A priority patent/KR101657637B1/en
Priority to ES08860577.9T priority patent/ES2525704T3/en
Priority to AU2008334637A priority patent/AU2008334637B2/en
Priority to EA201000787A priority patent/EA022913B1/en
Priority to US12/746,837 priority patent/US20110014182A1/en
Priority to CA2707859A priority patent/CA2707859A1/en
Priority to TW097147856A priority patent/TWI388334B/en
Priority to JP2010537424A priority patent/JP5512537B2/en
Priority to US12/330,541 priority patent/US8921523B2/en
Priority to ARP080105335A priority patent/AR069610A1/en
Priority to EP08860577.9A priority patent/EP2222705B1/en
Priority to CL2008003655A priority patent/CL2008003655A1/en
Priority to NZ586003A priority patent/NZ586003A/en
Priority to KR1020107015248A priority patent/KR101629365B1/en
Priority to PE2008002026A priority patent/PE20091449A1/en
Priority to BRPI0819916-7A priority patent/BRPI0819916A2/en
Priority to CN200880126884.8A priority patent/CN101970484B/en
Priority to UY31520A priority patent/UY31520A1/en
Priority to PCT/EP2008/067138 priority patent/WO2009074583A1/en
Priority to MX2010006422A priority patent/MX2010006422A/en
Priority to IL206188A priority patent/IL206188A0/en
Priority to CO10068844A priority patent/CO6280540A2/en
Priority to DO2010000170A priority patent/DOP2010000170A/en
Priority to ZA2010/04133A priority patent/ZA201004133B/en
Priority to MA32987A priority patent/MA31999B1/en
Priority to CR11561A priority patent/CR11561A/en
Priority to JP2014062826A priority patent/JP2014177462A/en
Ceased legal-status Critical Current

Links

GB0806230A 2007-12-11 2008-04-04 Antibodies Ceased GB0806230D0 (en)

Priority Applications (28)

Application Number Priority Date Filing Date Title
GB0806230A GB0806230D0 (en) 2008-04-04 2008-04-04 Antibodies
MX2010006422A MX2010006422A (en) 2007-12-11 2008-12-09 Antigen binding proteins.
CL2008003655A CL2008003655A1 (en) 2007-12-11 2008-12-09 Antibody that recognizes residues 28-35 of beta-amyloid peptide, a pharmaceutical composition that comprises it, useful for treating a disease related to beta-amyloid peptide.
KR1020107015248A KR101629365B1 (en) 2007-12-11 2008-12-09 Antigen binding proteins
AU2008334637A AU2008334637B2 (en) 2007-12-11 2008-12-09 Antigen binding proteins
EA201000787A EA022913B1 (en) 2007-12-11 2008-12-09 Antigen binding proteins
US12/746,837 US20110014182A1 (en) 2007-12-11 2008-12-09 Antigen binding proteins
CA2707859A CA2707859A1 (en) 2007-12-11 2008-12-09 Antigen binding proteins specific against beta amyloid
TW097147856A TWI388334B (en) 2007-12-11 2008-12-09 Antigen binding proteins
JP2010537424A JP5512537B2 (en) 2007-12-11 2008-12-09 Antigen binding protein
US12/330,541 US8921523B2 (en) 2007-12-11 2008-12-09 Humanized anti-beta-amyloid antibodies
ARP080105335A AR069610A1 (en) 2007-12-11 2008-12-09 PROTEINS OF UNION TO ANTIGENS THAT JOIN THE BETA-AMYLOID PEPTIDE
EP08860577.9A EP2222705B1 (en) 2007-12-11 2008-12-09 Antigen binding proteins
KR1020157022610A KR101657637B1 (en) 2007-12-11 2008-12-09 Antigen binding proteins
NZ586003A NZ586003A (en) 2007-12-11 2008-12-09 Antigen binding proteins that bind beta-amyloid peptide
ES08860577.9T ES2525704T3 (en) 2007-12-11 2008-12-09 Antigen binding proteins
PE2008002026A PE20091449A1 (en) 2007-12-11 2008-12-09 ANTIGEN BINDING PROTEINS
BRPI0819916-7A BRPI0819916A2 (en) 2007-12-11 2008-12-09 Antigen binding protein, pharmaceutical composition, method for treating a human patient afflicted with a disease, antibody or fragment thereof, and antigen binding protein.
CN200880126884.8A CN101970484B (en) 2007-12-11 2008-12-09 Antigen binding proteins
UY31520A UY31520A1 (en) 2007-12-11 2008-12-09 PROTEINS OF UNION TO ANTIGENS
PCT/EP2008/067138 WO2009074583A1 (en) 2007-12-11 2008-12-09 Antigen binding proteins
IL206188A IL206188A0 (en) 2007-12-11 2010-06-06 Antigen binding proteins
CO10068844A CO6280540A2 (en) 2007-12-11 2010-06-08 BETA-AMYLOID UNION PROTEINS THAT INCLUDE ANTIBODIES, ANTIBODY FRAGMENTS AND OTHER PROTEIN CONSTRUCTIONS
DO2010000170A DOP2010000170A (en) 2007-12-11 2010-06-09 PROTEINS OF UNION TO ANTIGENS
ZA2010/04133A ZA201004133B (en) 2007-12-11 2010-06-09 Antigen binding proteins
MA32987A MA31999B1 (en) 2007-12-11 2010-07-05 Protein binding by antigen
CR11561A CR11561A (en) 2007-12-11 2010-07-09 Antigen binding proteins
JP2014062826A JP2014177462A (en) 2007-12-11 2014-03-26 Antigen-binding proteins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0806230A GB0806230D0 (en) 2008-04-04 2008-04-04 Antibodies

Publications (1)

Publication Number Publication Date
GB0806230D0 true GB0806230D0 (en) 2008-05-14

Family

ID=39433201

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0806230A Ceased GB0806230D0 (en) 2007-12-11 2008-04-04 Antibodies

Country Status (1)

Country Link
GB (1) GB0806230D0 (en)

Similar Documents

Publication Publication Date Title
EP3064512C0 (en) Anti-cldn6 antibody
ZA201102119B (en) Improved antibody libraies
GB0708002D0 (en) Antibodies
GB0821100D0 (en) Antibodies
IL214996A0 (en) Anti-bcma antibodies
GB0920127D0 (en) Antibodies
GB0909906D0 (en) Antibodies
EP2337798A4 (en) Bsa-specific antibodies
HK1136970A1 (en) Penta-specific antibody
SI2200700T1 (en) Novel antibodies
EP2377932A4 (en) ANTI-Siglec-15 ANTIBODY
EP2138576A4 (en) Anti-claudin-4 antibody
EP2427496A4 (en) Anti-vegf-d antibodies
EP2172483A4 (en) ANTI-Muc17 ANTIBODY
GB0718737D0 (en) Antibodies
ZA201006099B (en) Anti-tyrp1 antibodies
GB0702888D0 (en) Novel Antibodies
IL205073A0 (en) Anti-bst2 antibody
GB0920324D0 (en) Antibodies
HK1170745A1 (en) Antibodies against il-17br il-17br
ZA201007976B (en) Anti-pirb antibodies
GB0818356D0 (en) Antibodies
EP2304439A4 (en) Anti-phospho-akt antibodies
EP2499256A4 (en) Anti-c-mpl antibodies
GB201015713D0 (en) Antibody

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)